- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: azd3355.
Displaying page 1 of 1.
EudraCT Number: 2006-003541-16 | Sponsor Protocol Number: D9120C00011 | Start Date*: 2006-11-07 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, multi-centre, phase IIA study to assess the effect on GERD symptoms, pharmacokinetics, safety and tolerability of four weeks treatment with AZD3355 6... | |||||||||||||
Medical condition: Gastroesophageal Reflux Disease (GERD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NO (Completed) NL (Completed) DE (Completed) HU (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012935-13 | Sponsor Protocol Number: D9120C00019 | Start Date*: 2009-12-03 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, multi-centre phase IIb dose finding study to assess the effect on GERD symptoms, safety and tolerability during four weeks treatment with AZD3355 in ... | |||||||||||||
Medical condition: Gastroesophageal Reflux Disease (GERD) is the intended indication. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LV (Completed) HU (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004501-25 | Sponsor Protocol Number: D9120C00020 | Start Date*: 2006-12-18 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A double-blind, placebo controlled, randomized, two centre phase IIa pharmacodynamic cross-over study to assess the effect of AZD3355, 65 mg bid, on transient lower esophageal sphincter relaxations... | |||||||||||||
Medical condition: Gastroesophageal Reflux Disease (GERD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005074-11 | Sponsor Protocol Number: 14/GAR/002 | Start Date*: 2015-04-29 | |||||||||||
Sponsor Name:University Hospital South Manchester NHS Foundation Trust | |||||||||||||
Full Title: The Role of GABAb receptor mechanisms in cough: Double-blind randomised controlled trial of Lesogaberan in Chronic cough patients with positive and negative symptom association probabilities | |||||||||||||
Medical condition: Chronic cough | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.